Terms: = Breast cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
3670 results:
1. Activation of the MEK/erk Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract] [Full Text] [Related]
3. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent erk1/2 Inhibitors.
Shuai W; Xiao H; Yang P; Zhang Y; Bu F; Wu Y; Sun Q; Wang G; Ouyang L
J Med Chem; 2024 Apr; 67(8):6425-6455. PubMed ID: 38613499
[TBL] [Abstract] [Full Text] [Related]
4. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative breast cancer.
Tang C; Jiang ST; Li CX; Jia XF; Yang WL
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
[TBL] [Abstract] [Full Text] [Related]
5. TIM3 activates the erk1/2 pathway to promote invasion and migration of thyroid tumors.
Jin X; Yin Z; Li X; Guo H; Wang B; Zhang S; Li Y
PLoS One; 2024; 19(4):e0297695. PubMed ID: 38568917
[TBL] [Abstract] [Full Text] [Related]
6. Parabens promotes invasive properties of multiple human cells: A potential cancer-associated adverse outcome pathway.
Wang L; Chen L; Schlenk D; Li F; Liu J
Sci Total Environ; 2024 May; 926():172015. PubMed ID: 38547973
[TBL] [Abstract] [Full Text] [Related]
7. SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: A potential therapeutic target.
Li Y; Yang W; Liu C; Zhou S; Liu X; Zhang T; Wu L; Li X; Zhang J; Chang E
Int Immunopharmacol; 2024 May; 132():111918. PubMed ID: 38537539
[TBL] [Abstract] [Full Text] [Related]
8. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
Cerutti C; Lucotti S; Menendez ST; Reymond N; Garg R; Romero IA; Muschel R; Ridley AJ
Cell Rep; 2024 Apr; 43(4):113989. PubMed ID: 38536816
[TBL] [Abstract] [Full Text] [Related]
9. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.
Priyanka HP; Pratap UP; Nair RS; Vasantharekha R; ThyagaRajan S
Med Oncol; 2024 Mar; 41(5):92. PubMed ID: 38526769
[TBL] [Abstract] [Full Text] [Related]
10. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
[TBL] [Abstract] [Full Text] [Related]
11. Altered hormone expression induced genetic changes leads to breast cancer.
Thakur A; Rana N; Kumar R
Curr Opin Oncol; 2024 Mar; 36(2):115-122. PubMed ID: 38441060
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of tyrosine kinase inhibitors examined by a combination of Raman micro-spectroscopy and a deep wavelet scattering-based multivariate analysis framework.
Schuler I; Schuler M; Frick T; Jimenez D; Maghnouj A; Hahn S; Zewail R; Gerwert K; El-Mashtoly SF
Analyst; 2024 Mar; 149(7):2004-2015. PubMed ID: 38426854
[TBL] [Abstract] [Full Text] [Related]
13. Phloretin Inhibits the Proliferation of breast cancer Cells Through the Down-regulation of Estrogen Receptor α.
Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
[TBL] [Abstract] [Full Text] [Related]
14. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast.
Pandithar S; Galke D; Akume A; Belyakov A; Lomonaco D; Guerra AA; Park J; Reff O; Jin K
Mol Biol Rep; 2024 Feb; 51(1):331. PubMed ID: 38393465
[TBL] [Abstract] [Full Text] [Related]
15. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
16. The Herbal Combination Shu Gan Jie Yu Regulates the SNCG/ER-a/AKT-erk Pathway in DMBA-Induced breast cancer and breast cancer Cell Lines Based on RNA-Seq and IPA Analysis.
Zhao Y; Zhao L; Wang T; Liu Z; Tang S; Huang H; Wu L; Sun Y
Integr Cancer Ther; 2024; 23():15347354241233258. PubMed ID: 38369762
[TBL] [Abstract] [Full Text] [Related]
17. Beauvericin, produced by Fusarium oxysporum inhibits bisphenol A-induced proliferation of human breast cancer cell line by regulating ERα/p38 pathway.
Jeong DH; Jung DW; Kim JW; Lee HS
J Steroid Biochem Mol Biol; 2024 May; 239():106483. PubMed ID: 38369033
[TBL] [Abstract] [Full Text] [Related]
18. The antipsychotic drug pimozide promotes apoptosis through the RAF/erk pathway and enhances autophagy in breast cancer cells.
Jiang G; Zhou X; Hu Y; Tan X; Wang D; Yang L; Zhang Q; Liu S
Cancer Biol Ther; 2024 Dec; 25(1):2302413. PubMed ID: 38356266
[TBL] [Abstract] [Full Text] [Related]
19. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating erk signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
20. Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression.
Deng Y; Hou Z; Li Y; Yi M; Wu Y; Zheng Y; Yang F; Zhong G; Hao Q; Zhai Z; Wang M; Ma X; Kang H; Ji F; Dong C; Liu H; Dai Z
Cell Commun Signal; 2024 Feb; 22(1):115. PubMed ID: 38347536
[TBL] [Abstract] [Full Text] [Related]
[Next]
